Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
Status:
Not yet recruiting
Trial end date:
2026-10-01
Target enrollment:
Participant gender:
Summary
Investigators will test a novel protocol for starting BUP (buprenorphine-naloxone) treatment.
The BUP microdose induction protocol has participants start very low doses of BUP without
stopping other opioids that they are taking. The treatment as usual (TAU) has participants
stop other opioids and experience opioid withdrawal before starting BUP. Investigators
propose to test BUP microdose inductions vs. TAU in a randomized controlled trial.